Advanced HIV Disease: Know Your Count

It's estimated that four out of 10 HIV-related deaths could be prevented by dealing with Advanced HIV Disease, or AHD. People living with AHD are also at greater risk of contracting opportunistic infections such as tuberculosis and cryptococcal meningitis. Yet why do people continue to die from AHD when diagnostic services and treatment exist? This series looks at how this can be changed by sharing insights from practitioners, policymakers, and people living with AHD.

Read More ↓
Overcoming obstacles to diagnosing and treating advanced HIV disease

Overcoming obstacles to diagnosing and treating advanced HIV disease

While progress has been made on expanding access to antiretroviral treatment, much remains to be done to diagnose and treat advanced HIV disease. Devex explores how several African countries are tackling AHD and the challenges that remain.

Explore the Visual Story
CD4 testing — still the best measurement to identify advanced HIV disease

CD4 testing — still the best measurement to identify advanced HIV disease

Despite significant progress in the fight against HIV, approximately one-third of all people living with HIV only present to care by the time the virus has severely weakened their immune systems and they are at an advanced stage of the disease.

Explore the Visual Story

Explore all the content

Q&A: Tackling advanced HIV disease and stigma in key populations

Q&A: Tackling advanced HIV disease and stigma in key populations
By Devex Partnerships

Access to HIV treatment and care can be particularly difficult for a number of groups such as men who have sex with men, and sex workers. Devex spoke to a former sex worker turned advocate about the challenges facing the LGBTQ community in Malawi.

Read The Article
Opinion: Ensuring services for people with advanced HIV disease — more important than ever

Opinion: Ensuring services for people with advanced HIV disease — more important than ever
By Laura Broyles, Debi Boeras, Renuka Gadde

The global health community is increasingly concerned about COVID-19's impact on the 37.9 million people living with HIV globally. We hear why it's vital that testing and treatment services are available during health crises.

Read The Article
Safety First

What do you think of this series on Advanced HIV Disease?

Your feedback is important to us.

Share on social media using

#AdvancedHIV
#DevexSERIES

More Devex News on Advanced HIV Disease

Preventing deaths from advanced HIV disease: Highlights from ICASA 2019

Preventing deaths from advanced HIV disease: Highlights from ICASA 2019

By Devex Editor

While important strides have been made to stall the HIV epidemic, much remains to be done to decrease the number of deaths from advanced HIV disease. In Rwanda, Devex explores some of the barriers to and opportunities for meeting the UNAIDS 2020 goals for reducing AIDS-related mortality.

Read the article
Confronting missed targets, HIV/AIDS experts emphasize drug delivery

Confronting missed targets, HIV/AIDS experts emphasize drug delivery

By Catherine Cheney

Ideas to close the gap between innovation and uptake for HIV/AIDS hold important lessons for a range of global health priorities — where work on research and development is not paired with a plan for delivery.

Read the article
Unlocking HIV/AIDS financing during COVID-19

Unlocking HIV/AIDS financing during COVID-19

By Jenny Lei Ravelo

What can be done to mitigate the financial impact of COVID-19 on country resources and maintain sufficient funding for programs, such as those targeting HIV/AIDS?

Read the article

Produced by

Devex

Devex

Devex is the media platform for the global development community. A social enterprise, we connect and inform over one million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people.

Sponsored by

BD

BD

BD is a medical technology company that serves health care institutions, life science researchers, clinical laboratories, industry and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. BD is headquartered in the United States and has offices in more than 50 countries worldwide.